Registration Dossier

Diss Factsheets

Toxicological information

Carcinogenicity

Currently viewing:

Administrative data

Description of key information

Available evidence suggests classifying compactin /mevastatin/ as a Cat 2 carcinogen, H351: Suspectid of causing cancer

Key value for chemical safety assessment

Justification for classification or non-classification

Available evidence suggests classifying compactin /mevastatin/ as a Cat 2 carcinogen, H351: Suspectid of causing cancer.

Additional information

Available evidence suggests classifying compactin /mevastatin/ as a Cat 2 carcinogen, H351: Suspectid of causing cancer